Estrogen and Your Heart: It Is Time to Move Beyond the Fear
- deeprooted1
- Jul 19
- 6 min read
A woman recently asked me, “If estrogen is supposed to help protect my heart, why have women been warned for so many years that hormone replacement therapy causes heart attacks?”
That is a very good question.
My answer was simple: We cannot put every estrogen, every delivery method, and every woman into the same box.
For more than two decades, women have been frightened by headlines suggesting that menopausal hormone therapy is inherently dangerous. Those headlines rarely explain what type of estrogen was studied, whether it was taken orally or delivered directly into the bloodstream, what type of progesterone was used, how old the women were when treatment began, or how many years had passed since menopause.
Those details matter.
The conversation surrounding estrogen has changed significantly as researchers have revisited the evidence. In fact, in 2026, the FDA approved labeling changes removing broad cardiovascular, breast cancer, and dementia risk statements from the boxed warnings of several menopausal hormone therapy products. This does not mean that hormone therapy is appropriate for every woman. It does mean that the old message—“estrogen is dangerous”—was far too simplistic.
What concerns me just as much as the potential risks of hormone therapy are the health consequences of leaving estrogen deficiency unrecognized and untreated.
Your Heart Notices the Loss of Estrogen
Most women recognize hot flashes, night sweats, vaginal dryness, poor sleep, brain fog, and changes in sexual function as possible signs of menopause. What they may not realize is that estrogen receptors are located throughout the cardiovascular system.
Estrogen influences the health and flexibility of blood vessels, cholesterol metabolism, glucose regulation, inflammation, fat distribution, and nitric oxide production. Nitric oxide helps blood vessels relax and supports healthy circulation.
When estrogen begins to decline during perimenopause and menopause, changes may occur beneath the surface long before a woman develops cardiovascular symptoms.
These changes may include:
An increase in LDL cholesterol
Changes in the function and protective quality of HDL cholesterol
An increase in triglycerides
Greater insulin resistance
Rising fasting glucose and hemoglobin A1c
Increased abdominal and visceral fat
Loss of lean muscle mass
Increased vascular stiffness
Reduced nitric oxide production
Increased inflammation and oxidative stress
Changes in blood pressure
Sleep disruption and increased stress-hormone activity
This is why menopause is not simply the end of a menstrual cycle. It represents a major metabolic and cardiovascular transition.
Many women tell me, “I have not changed what I eat, so why is my cholesterol higher? Why is my blood pressure changing? Why am I suddenly gaining weight around my waist?”
The answer is not always a lack of discipline. Sometimes the internal environment has changed.
Estrogen Is Not the Enemy
Estrogen supports several functions that are important to cardiovascular health. It can help promote healthy blood-vessel dilation, influence lipid metabolism, support insulin sensitivity, and reduce some of the metabolic changes associated with estrogen decline.
That does not mean estrogen is prescribed as a stand-alone treatment to prevent heart disease. It means that replacing estrogen in an appropriately selected woman may support a healthier cardiovascular environment while also treating disruptive menopausal symptoms.
The timing of therapy matters. Current evidence shows a more favorable benefit-to-risk profile when menopausal hormone therapy is started in healthy, symptomatic women who are younger than 60 or within approximately 10 years of menopause.
This is sometimes called the “window of opportunity.”
Starting hormone therapy near the menopause transition is very different from initiating it decades later, after advanced atherosclerosis or cardiovascular disease may already be present. Unfortunately, older studies often combined women of different ages and stages of menopause, then applied the conclusions broadly to all women.
That is not personalized medicine, and it does not tell the whole story.
Not All Estrogen Is Delivered the Same Way
One of the most important points missing from many discussions is the route of administration.
Oral estrogen must pass through the liver before entering the general circulation. This is known as first-pass metabolism. During that process, oral estrogen can affect clotting proteins, triglycerides, inflammatory markers, and other liver-mediated pathways.
That does not mean every woman taking oral estrogen will develop a blood clot or cardiovascular event. It means oral administration creates a different metabolic effect than nonoral estrogen.
Transdermal estrogen—delivered through a patch, gel, or cream—enters the circulation through the skin and avoids much of this first-pass liver metabolism. Evidence suggests that transdermal estradiol has a more favorable effect on coagulation and is associated with a lower risk of venous thromboembolism than oral estrogen.
This distinction is critical. A study finding increased cardiovascular risk with a specific oral formulation should not be used to claim that every type of hormone therapy carries the same risk.
That is like studying fried fish, finding an adverse health effect, and concluding that all fish must be unhealthy. The fish was not the only variable. How it was prepared mattered.
The same principle applies to estrogen.
Where Does Pellet Therapy Fit?
Bioidentical hormone pellet therapy is another nonoral delivery option. A small pellet is placed beneath the skin, where it gradually releases hormone into the bloodstream. Because the hormone does not have to pass through the gastrointestinal system before reaching circulation, pellets also avoid first-pass liver metabolism.
Potential advantages include:
Consistent hormone delivery
Fewer daily fluctuations
No need to remember a daily pill
Long-lasting symptom support
Individualized dosing based on the patient’s needs
Avoidance of first-pass liver metabolism
Improved treatment adherence for appropriately selected patients
This physiologic difference is one reason it is inappropriate to apply data from older oral estrogen and synthetic progestin studies directly to bioidentical estradiol pellet therapy.
Research specifically evaluating long-term cardiovascular outcomes with estradiol pellets is still developing. Therefore, I do not tell women that pellets are a guaranteed way to prevent a heart attack or stroke. I explain that pellets are a nonoral option with a different delivery mechanism than oral estrogen and may be considered as part of a carefully monitored, individualized treatment plan.
At Deep Rooted Health & Wellness Med Spa, pellet therapy is not simply an insertion procedure. It begins with understanding the woman receiving the pellet.
Looking at the Woman, Not Just the Hormone Level
Before considering BHRT, I want to understand the patient’s complete cardiovascular and metabolic picture.
That may include reviewing:
Blood pressure
Waist circumference and body composition
Fasting glucose, insulin, and hemoglobin A1c
Standard and advanced lipid markers
Apolipoprotein B
Lipoprotein(a)
Thyroid function
Liver and kidney function
Personal and family history of blood clots
Personal and family history of premature cardiovascular disease
Smoking history
Sleep quality and possible sleep apnea
Nutrition and physical activity
Menopause symptoms and their severity
Previous pregnancy complications, including preeclampsia or gestational diabetes
Women who still have a uterus also require appropriate endometrial protection when receiving systemic estrogen. Hormone balance does not mean replacing one hormone while ignoring how it interacts with the rest of the body.
This is where functional medicine becomes especially valuable. I am not treating a laboratory number. I am looking at the roots contributing to the woman’s symptoms and long-term health risks.
BHRT Works Best as Part of a Larger Plan
Restoring estrogen may support sleep, energy, body composition, sexual health, bone health, and overall quality of life. Better sleep may make it easier to regulate cortisol and blood pressure. Improved energy may help a woman return to exercise. Preserving lean muscle can support insulin sensitivity and healthy aging.
These changes are connected.
However, estrogen cannot replace nutritious food, strength training, movement, stress regulation, adequate protein, restorative sleep, healthy relationships, or the treatment of hypertension and diabetes.
BHRT should complement these foundations—not compete with them.
My goal is not simply to help a woman stop having hot flashes. I want to know what her cholesterol is doing, whether she is developing insulin resistance, how much muscle she is preserving, how well she is sleeping, and what her cardiovascular health may look like 10 or 20 years from now.
The Message Women Deserve to Hear
Women deserve more than fear-based medicine.
They deserve to know that the loss of estrogen has consequences beyond hot flashes. They deserve to understand that oral, topical, and pellet hormone therapies are not metabolically identical. They deserve an honest discussion about timing, delivery method, personal risk factors, and the potential benefits of treatment.
Most importantly, women deserve to participate in the decision instead of being dismissed with, “This is just part of getting older.”
Menopause is natural. Suffering through it without information, evaluation, or options should not be considered mandatory.
At Deep Rooted Health & Wellness Med Spa, we approach BHRT with careful evaluation, individualized dosing, ongoing monitoring, and a commitment to caring for the whole woman. The question is not simply, “Is estrogen safe?” The better question is:
Is this the right hormone, delivered by the right method, at the right dose, at the right time, for this particular woman?
That is the conversation we should have been having all along.
Because when we heal at the root, we empower individuals, strengthen families, and transform communities.
This article is for educational purposes and does not replace individualized medical care. Menopausal hormone therapy should be considered after reviewing a woman’s symptoms, personal and family history, cardiovascular risk factors, contraindications, and treatment goals.
Comments